Mads Hald Andersen
Clinical Professor
Immunology
Blegdamsvej 3B, 2200 København N
Member of:
- 2024
- Accepted/In press
Increased myeloid-derived suppressor cell activation in clonal cytopenia of undetermined significance and low-risk myelodysplastic syndrome
Bentivegna, Sofia, Côme, Christophe Roger Michel, Porse, Bo Torben, Andersen, Mads Hald & Grønbæk, Kirsten, 2024, (Accepted/In press) In: British Journal of Haematology.Research output: Contribution to journal › Letter › Research › peer-review
- E-pub ahead of print
The CALR mutations enhance the expression of the immunosuppressive proteins GARP and LAP on peripheral blood lymphocytes through increased binding of activated platelets
Holmström, M. O., Ruders, J. H., Riley, C. H., Larsen, Morten Kranker, Grauslund, J. H., Kjær, L., Skov, V., Ellervik, Christina, Guo, B. B., Linden, M., Hasselbalch, Hans Carl & Andersen, Mads Hald, 2024, (E-pub ahead of print) In: British Journal of Haematology. 13 p.Research output: Contribution to journal › Journal article › Research › peer-review
- 2023
- Published
of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes
Hulen, T. M., Friese, C., Kristensen, N. P., Granhøj, J. S., Borch, T. H., Peeters, M. J. W., Donia, M., Andersen, Mads Hald, Hadrup, S. R., Svane, Inge Marie & Met, Özcan, 2023, In: Frontiers in Immunology. 14, 15 p., 1180997.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
An arginase1- and PD-L1-derived peptide-based vaccine for myeloproliferative neoplasms: A first-in-man clinical trial
Grauslund, J. H., Holmström, M. O., Martinenaite, E., Lisle, T. L., Glöckner, H. J., Fassi, Daniel El , Klausen, U., Mortensen, R. E. J., Jørgensen, N., Kjær, L., Skov, V., Svane, Inge Marie, Hasselbalch, Hans Carl & Andersen, Mads Hald, 2023, In: Frontiers in Immunology. 14, 14 p., 1117466.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Antibodies to calnexin and mutated calreticulin are common in human sera
Kyllesbech, C., Trier, N. H., Mughal, F. P., Hansen, Paul Robert, Holmström, M. O., Fassi, Daniel El , Hasselbalch, H., Skov, V., Kjær, L., Andersen, Mads Hald, Ciplys, E., Slibinskas, R., Fredriksen, Jette Lautrup, Højrup, P. & Houen, G., 2023, In: Current Research in Translational Medicine. 71, 2, 103380.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
First in man study: Bcl-Xl_42-CAF®09b vaccines in patients with locally advanced prostate cancer
Mørk, S. K., Kongsted, P., Westergaard, M. C. W., Albieri, B., Granhøj, J. S., Donia, M., Martinenaite, E., Holmström, M. O., Madsen, K., Kverneland, A. H., Kjeldsen, J. W., Holmstroem, R. B., Lorentzen, C. L., Nørgaard, N., Andreasen, L. V., Wood, G. K., Christensen, D., Klausen, M. S., Hadrup, S. R., thor Straten, P. & 2 others, , 2023, In: Frontiers in Immunology. 14, 1122977.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Immune modulatory vaccines: time to move into infectious diseases
Andersen, Mads Hald, 2023, In: The Lancet Microbe. 4, 1, p. e4-e5Research output: Contribution to journal › Comment/debate › Research › peer-review
- Published
Novel immune modulatory vaccines targeting TGFβ
Andersen, Mads Hald, 2023, In: Cellular and Molecular Immunology. 20, p. 551–553Research output: Contribution to journal › Comment/debate › Research › peer-review
- Published
Novel immunotherapeutic combinations moving forward: the modulation of the immunosuppressive microenvironment
Andersen, Mads Hald, 2023, In: Seminars in Immunopathology. 45, 2, p. 159-161 3 p.Research output: Contribution to journal › Editorial › Research › peer-review
- Published
Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy
Mortensen, R. E. J., Holmström, M. O., Lisle, T. L., Hasselby, Jane Preuss, Willemoe, G. L., Met, Özcan, Svane, Inge Marie, Johansen, Julia Sidenius, Nielsen, Dorte Lisbet, Chen, I. M. & Andersen, Mads Hald, 2023, In: Journal for ImmunoTherapy of Cancer. 11, 3Research output: Contribution to journal › Journal article › Research › peer-review
ID: 13571778
Most downloads
-
222
downloads
Butyrate and propionate inhibit antigen-specific CD8+ T cell activation by suppressing IL-12 production by antigen-presenting cells
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
176
downloads
Low antigen dose formulated in CAF09 adjuvant Favours a cytotoxic T-cell response following intraperitoneal immunization in Göttingen minipigs
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
173
downloads
Interleukin-26 (IL-26) is a novel anti-microbial peptide produced by T cells in response to staphylococcal enterotoxin
Research output: Contribution to journal › Journal article › Research › peer-review
Published